Search
for

    Sort by

    Research 121–150 of 876

    1. Bilateral Trichotillomania of Eyelashes Triggered by Anxiety due to Nocturnal Enuresis: A Case Report Case Reports in Ophthalmological Medicine · 2019 · 4 citations
    2. Baricitinib Effectiveness and Patient Impressions in Routine Clinical Practice: 12-month Results from a Prospective Observational Real-world Study SKIN The Journal of Cutaneous Medicine · 2025
    3. Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment Skin Appendage Disorders · 2024
    4. Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2 Annales de dermatologie et de vénéréologie, FMC · 2023
    5. Clouston Syndrome: Report of a Jordanian Family with GJB6 Gene Mutation Case reports in dermatological medicine · 2023
    6. 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2 Journal of The American Academy of Dermatology · 2022
    7. An eruption of numerous spiny papules in a pediatric transplant patient American Journal of Transplantation · 2020
    8. Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life Cancer research · 2015
    9. Alopecia areata of eyelashes: Regrowth after injecting triamcinolone into the eyebrow area Journal of the American Academy of Dermatology · 2009 · 2 citations
    10. Regrowth of Upper Eyelid Eyelashes After Making a Surgical Incision on the Upper Eyelid in a Case of Severe Alopecia Areata Ophthalmic plastic and reconstructive surgery · 2013 · 1 citations
    11. Alopecia Areata Ophiasic with Ciliary Madarosis in A Pediatric Patient: Case Report Journal of Dermatology Research Reviews & Reports · 2025
    12. Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial The Journal of Dermatology · 2025 · 4 citations
    13. Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study Australasian Journal of Dermatology · 2026
    14. Minoxidil oral en dosis bajas en alopecia frontal fibrosante: serie de 122 pacientes Actas Dermo-Sifiliográficas · 2024
    15. Ritlecitinib in severe alopecia areata: a profile of its use Drugs & Therapy Perspectives · 2024
    16. P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2 British Journal of Dermatology · 2023
    17. Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials JAAD reviews. · 2025
    18. Hypertrichosis of the eyelashes caused by bimatoprost Journal of the American Academy of Dermatology · 2004 · 65 citations
    19. Ruxolitinib found to cause eyelash growth: a case report Journal of medical case reports · 2017 · 9 citations
    20. Facial Hair Restoration Facial Plastic Surgery Clinics of North America · 2013 · 37 citations
    21. Camouflage technique for alopecia areata: What is a patient to do? Dermatologic Therapy · 2011 · 19 citations
    22. Trichomegaly in a 3-Year-Old Girl with Alopecia Areata Pediatric dermatology · 2009 · 15 citations
    23. Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates Indian Journal of Dermatology · 2025
    24. Alopecia totalis in an infant Cosmoderma · 2023
    25. Alopecia Areata: An Evidence-Based Treatment Update American journal of clinical dermatology · 2014 · 72 citations
    26. Alopecia areata: a new treatment plan Clinical, cosmetic and investigational dermatology · 2011 · 67 citations
    27. Alopecia areata: Part 2: treatment. PubMed · 2015 · 14 citations
    28. Frontal fibrosing alopecia: A review of 60 cases Journal of The American Academy of Dermatology · 2012 · 166 citations
    29. Topical and intralesional therapies for alopecia areata Dermatologic therapy · 2011 · 36 citations
    30. Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata British Journal of Dermatology · 2024 · 23 citations